Mathematical modeling identifies Lck as a potential mediator for PD-1 induced inhibition of early TCR signaling.
Theinmozhi ArulrajDebashis BarikPublished in: PloS one (2018)
Programmed cell death-1 (PD-1) is an inhibitory immune checkpoint receptor that negatively regulates the functioning of T cell. Although the direct targets of PD-1 were not identified, its inhibitory action on the TCR signaling pathway was known much earlier. Recent experiments suggest that the PD-1 inhibits the TCR and CD28 signaling pathways at a very early stage ─ at the level of phosphorylation of the cytoplasmic domain of TCR and CD28 receptors. Here, we develop a mathematical model to investigate the influence of inhibitory effect of PD-1 on the activation of early TCR and CD28 signaling molecules. Proposed model recaptures several quantitative experimental observations of PD-1 mediated inhibition. Model simulations show that PD-1 imposes a net inhibitory effect on the Lck kinase. Further, the inhibitory effect of PD-1 on the activation of TCR signaling molecules such as Zap70 and SLP76 is significantly enhanced by the PD-1 mediated inhibition of Lck. These results suggest a critical role for Lck as a mediator for PD-1 induced inhibition of TCR signaling network. Multi parametric sensitivity analysis explores the effect of parameter uncertainty on model simulations.
Keyphrases
- regulatory t cells
- signaling pathway
- early stage
- pi k akt
- immune response
- radiation therapy
- oxidative stress
- risk assessment
- squamous cell carcinoma
- diabetic rats
- climate change
- induced apoptosis
- mass spectrometry
- cell proliferation
- high glucose
- drug induced
- dna methylation
- binding protein
- sentinel lymph node
- human health